ArticleCureus2024
Parallel Battles: Managing Synchronous Cervical and Triple-Negative Breast Cancers.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Simultaneous Occurrence of Breast Cancer Metastases and Cervical Cancer Metastases in the Same Lymph Node.Case reports in obstetrics and gynecology · 2026Article
- A case of metachronous cervical and early-stage breast cancer.Discover oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple primary malignancies (MPMs) present diagnostic and therapeutic challenges, especially given their rarity and the distinct treatment strategies required. We report a case of a 66-year-old postmenopausal woman who presented with synchronous triple-negative breast cancer (TNBC) and cervical cancer, an uncommon and complex clinical scenario. Given the complexity of her condition, a comprehensive multidisciplinary approach was employed. The treatment strategy included neoadjuvant chemotherapy for breast cancer, followed by breast-conserving surgery and axillary lymph node dissection. Simultaneously, cervical cancer was addressed with concurrent chemoradiotherapy and brachytherapy. Remarkably, the patient demonstrated complete pathological responses in both the breast and cervical tumors following treatment. At 26 months of follow-up, she remains free of disease recurrence. This case highlights the challenges of managing synchronous TNBC and cervical cancer. It underscores the necessity for individualized treatment plans and seamless multidisciplinary collaboration to achieve optimal patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.